Stemcentrx

About Stemcentrx

Our mission is to develop therapies that cure and significantly improve survival for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors.

Stemcentrx was acquired by Abbvie (www.abbvie.com) in April 2016.

Status

Acquired

twitter

@stemcentrx

Recent tweets

Sorry, No Tweets

Blog and Press

AbbVie to Buy Cancer Treatment Start-Up

In Silicon Valley, being a unicorn is no guarantee of financial success. But an eight-year...

Apr 28, 2016

Press